{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:56:31Z","timestamp":1794851791533,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["9800446"],"award-info":[{"award-number":["9800446"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002660","name":"Islamic Azad University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.heliyon.2023.e20430","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T21:43:28Z","timestamp":1695678208000},"page":"e20430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exploring mesoporous silica nanoparticles as oral insulin carriers: In-silico and in vivo evaluation"],"prefix":"10.1016","volume":"9","author":[{"given":"Ehsan","family":"Salarkia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdis","family":"Mehdipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-6331","authenticated-orcid":false,"given":"Elahe","family":"Molaakbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-0704","authenticated-orcid":false,"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-4643","authenticated-orcid":false,"given":"Mohammad Reza","family":"Sazegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Dabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyavash","family":"Joukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-1526","authenticated-orcid":false,"given":"Guogang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e20430_bib1","series-title":"Diabetes Atlas","year":"2022"},{"key":"10.1016\/j.heliyon.2023.e20430_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/nnm-2021-0338","article-title":"Recent advances in the application of nanomedicine for the treatment of diabetes","volume":"17","author":"Vemana","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.heliyon.2023.e20430_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10358","article-title":"Molecular and cellular effects of gold nanoparticles treatment in experimental diabetic myopathy","volume":"8","author":"Al-Shwaheen","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2023.e20430_bib4","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.heliyon.2023.e20430_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/pharmaceutics14071406","article-title":"A comprehensive review of the evolution of insulin development and its delivery method","volume":"14","author":"Sugumar","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2023.e20430_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijbiomac.2022.03.144","article-title":"An overview of oral insulin delivery strategies (OIDS)","volume":"208","author":"Iyer","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e20430_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2018.12.006","article-title":"Advances in transdermal insulin delivery","volume":"139","author":"Zhang","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e20430_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122623","article-title":"Advances in buccal and oral delivery of insulin","author":"Elsayed","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e20430_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2022.11.032","article-title":"Insulin-loaded liposomes packaged in alginate hydrogels promote the oral bioavailability of insulin","volume":"353","author":"Wu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e20430_bib10","article-title":"Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes","author":"Pang","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2023.e20430_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.886981","article-title":"Biocompatible supramolecular mesoporous silica nanoparticles as the next-generation drug delivery system","volume":"13","author":"Mohamed","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e20430_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/coatings12030358","article-title":"Multifunctional mesoporous silica nanoparticles for oral drug delivery","volume":"12","author":"Sreeharsha","year":"2022","journal-title":"Coatings"},{"key":"10.1016\/j.heliyon.2023.e20430_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cej.2013.12.004","article-title":"Protonation of Al-grafted mesostructured silica nanoparticles (MSN): acidity and catalytic activity for cumene conversion","volume":"240","author":"Sazegar","year":"2014","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.heliyon.2023.e20430_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcis.2020.08.010","article-title":"Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers","volume":"582","author":"Gao","year":"2020","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.heliyon.2023.e20430_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.045","article-title":"Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery","volume":"342","author":"Xi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e20430_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/2215083805666191001220342","article-title":"Molecular docking studies and pharmacophore modeling of some insulin mimetic agents from herbal sources: a rational approach towards designing of orally active insulin mimetic agents","volume":"6","author":"Pradhan","year":"2020","journal-title":"Curr. Tradit. Med."},{"key":"10.1016\/j.heliyon.2023.e20430_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101255","article-title":"Understanding insulin and its receptor from their three-dimensional structures","volume":"52","author":"Lawrence","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.heliyon.2023.e20430_bib18","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1038\/s41467-022-33315-8","article-title":"Activation of the human insulin receptor by non-insulin-related peptides","volume":"13","author":"Kirk","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2023.e20430_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj3600189","article-title":"Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors","volume":"360","author":"Fl\u00f6rke","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2023.e20430_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167458","article-title":"Structural investigations of full-length insulin receptor dynamics and signalling","volume":"434","author":"Nielsen","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2023.e20430_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4838043","article-title":"An overview of nanomaterial applications in pharmacology","volume":"2023","author":"Roy","year":"2023","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2023.e20430_bib22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11030-022-10467-9","article-title":"Identification of potential matrix metalloproteinase-2 inhibitors from natural products through advanced machine learning-based cheminformatics approaches","volume":"27","author":"Yang","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.heliyon.2023.e20430_bib23","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.3390\/molecules180910829","article-title":"An insight into the anticancer activities of Ru (II)-based metallocompounds using docking methods","volume":"18","author":"Adeniyi","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e20430_bib24","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"A new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e20430_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109240","article-title":"Vascular alteration in relation to fosfomycine: in silico and in vivo investigations using a chick embryo model","volume":"118","author":"Tavakkoli","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2023.e20430_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/C0JM02395G","article-title":"Silver nanoparticles within vertically aligned multi-wall carbon nanotubes with open tips for antibacterial purposes","volume":"21","author":"Akhavan","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.heliyon.2023.e20430_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.micromeso.2018.07.018","article-title":"Synthesis of cobalt-modified MSN as a model enzyme: evaluation of the peroxidatic performance","volume":"274","author":"Hajiagha","year":"2019","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.heliyon.2023.e20430_bib28","doi-asserted-by":"crossref","first-page":"27506","DOI":"10.1039\/C7RA02280H","article-title":"Novel protonated Fe-containing mesoporous silica nanoparticle catalyst: excellent performance cyclohexane oxidation","volume":"7","author":"Sazegar","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2023.e20430_bib29","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1002\/chem.202000773","article-title":"Smart protein\u2010based formulation of dendritic mesoporous silica nanoparticles: toward oral delivery of insulin","volume":"26","author":"Ju\u00e8re","year":"2020","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.heliyon.2023.e20430_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/17425247.2018.1503250","article-title":"Silica nanoparticles on the oral delivery of insulin","volume":"15","author":"Tan","year":"2018","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.heliyon.2023.e20430_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200672","article-title":"Mesoporous silica nanoparticles: drug delivery vehicles for antidiabetic molecules","author":"Sarkar","year":"2023","journal-title":"Chembiochem"},{"key":"10.1016\/j.heliyon.2023.e20430_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ddr.21903","article-title":"Novel strategies to oral delivery of insulin: current progress of nanocarriers for diabetes management","volume":"83","author":"Abdel\u2010Moneim","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.heliyon.2023.e20430_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijbiomac.2022.10.274","article-title":"pH-sensitive O-carboxymethyl chitosan\/sodium alginate nanohydrogel for enhanced oral delivery of insulin","volume":"223","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e20430_bib34","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1080\/09205063.2022.2096527","article-title":"Biopolymeric nanocarrier: an auspicious system for oral delivery of insulin","volume":"33","author":"Panigrahy","year":"2022","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.heliyon.2023.e20430_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102848","article-title":"Surface design of nanocarriers: key to more efficient oral drug delivery systems","author":"Spleis","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.heliyon.2023.e20430_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a fasting-induced glucogenic protein hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2023.e20430_bib37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fchem.2019.00290","article-title":"Mesoporous silica nanoparticles for protein protection and delivery","volume":"7","author":"Xu","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.heliyon.2023.e20430_bib38","doi-asserted-by":"crossref","unstructured":"Y. Yang, S. Chen, Y. Liu, Y. Huang, K.-L. Cheong, B. Teng, W. Liu, Long-term treatment of polysaccharides-based hydrogel microparticles as oral insulin delivery in streptozotocin-induced type 2 diabetic mice, Biomed. Pharmacother. 133 (n.d.) 110941..","DOI":"10.1016\/j.biopha.2020.110941"},{"key":"10.1016\/j.heliyon.2023.e20430_bib39","first-page":"1","article-title":"Effects of long-term administration of oral sodium nitrate on liver enzyme concentrations in type 2 diabetic male rats, Iran","volume":"22","author":"Shokri","year":"2020","journal-title":"J. Endocrinol. Metab."},{"key":"10.1016\/j.heliyon.2023.e20430_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.colsurfb.2019.02.024","article-title":"Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats","volume":"177","author":"El-Naggar","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023076387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023076387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:31:16Z","timestamp":1790757076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023076387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405844023076387"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20430","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring mesoporous silica nanoparticles as oral insulin carriers: In-silico and in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e20430"}}